Human adipose-derived stem cells for the treatment of chemically burned rat cornea: Preliminary Results

Current Eye Research

Volumn 38, Issue 4, 2013, Pages 451-463

  Zeppieri, Marco ^a   Salvetat, Maria Letizia ^a   Beltrami, Antonio Paolo ^a   Cesselli, Daniela ^a   Bergamin, Natascha ^a   Russo, Rossella ^b   Cavaliere, Federica ^b   Varano, Giuseppe Pasquale ^b   Alcalde, Ignacio ^c   Merayo, Jesus ^c   Brusini, Paolo ^a   Beltrami, Carlo Alberto ^a   Parodi, Pier Camillo ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

^c Instituto Oftalmologico Fernandez Vega   (Spain)

Author keywords

Adipose derived stem cell; Cell therapy; Corneal re epithelization; Corneal wound healing; Lipoaspirate

Indexed keywords

5' NUCLEOTIDASE; AZITHROMYCIN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL BURN; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA BURN; CORNEA EPITHELIUM; CORNEA ULCER; EPITHELIZATION; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN CELL; HYPOTHERMIA; IN VITRO STUDY; INFLAMMATORY CELL; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL EXPANSION; WOUND HEALING;

ADIPOSE TISSUE; ANIMALS; BURNS, CHEMICAL; DISEASE MODELS, ANIMAL; EPITHELIUM, CORNEAL; EYE BURNS; FLUORESCENT DYES; HUMANS; MALE; PILOT PROJECTS; RATS; RATS, WISTAR; STAINING AND LABELING; STATISTICS, NONPARAMETRIC; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; WOUND HEALING;

EID: 84890573618     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.763100     Document Type: Article

References (36)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79:214-221.
2. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res 1999;18:529-551.
3. De Miguel MP, Alio JL, Arnalich-Montiel F Uentes-Julian S, De Benito-Llopis L, Amparo F, et al. Cornea and ocular surface treatment. Curr Stem Cell Res Ther 2010;5:195-204.
4. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467-1474.
5. Anitua E, Sanchez M, Merayo-Lloves J, De La Fuente M, Muruzabal F, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-betal-Induced myodifferentiation. Invest Ophthalmol Vis Sci 2011;52:6066-6073.
6. Tanidir ST, Yuksel N, Altintas O, Yildiz DK, Sener E, Caglar Y. The effect of subconjunctival platelet-rich plasma on corneal epithelial wound healing. Cornea 2010;29:664-669.
7. Du Y, Roh DS, Funderburgh ML, Mann MM, Marra KG, Rubin JP, Li X, et al. Adipose-derived stem cells differentiate to keratocytes in vitro. Mol Vis 2010;16:2680-2689.
8. Owen M, Friedenstein AJ. Stromal stem cells: marrowderived osteogenic precursors. Ciba Found Symp 1988;136:42-60.
9. Zuck PA, Zhu M, Ashjian P, De Ugarte DA, Huang JL Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
10. Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell 2010;21:1783-1787.
11. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-2529.
12. Casteilla L, Planat-Benard V, Laharrague P, Cousin B. Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells 2011;3:25-33.
13. Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissuederived cells. Stem Cell Res Ther 2010;1:19. doi: 10.1186/scrtl9.
14. Philippe B, Luc S, Valerie PB, Jerome R, Alessandra BR, Louis C. Culture and use of mesenchymal stromal cells in phase i and ii clinical trials. Stem Cells Int 2010;2010:503-593.
15. Arnalich-Montiel F, Pastor S, Blazquez-Martinez A, Fernandez-Delgado J, Nistal M, Alio JL, et al. Adiposederived stem cells are a source for cell therapy of the corneal stroma. Stem Cells 2008;26:570-579.
16. Ma Y, Xu Y, Xiao Z, Yang W, Zhang C, Song E, et al. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells 2006;24:315-321.
17. Oh JY Kim MK, Shin MS, Lee HJ, Ko JH, Wee WR, et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 2008;26:1047-1055.
18. Bae SR, Park C, Choi JC, Poo H, Kim CJ, Sung MH. Effects of ultra high molecular weight poly-gamma-glutamic acid from Bacillus subtilis (chungkookjang) on corneal wound healing. J Microbiol Biotechnol 2010;20:803-808.
19. Merayo-Lloves J, Blanco-Mezquita T, Ibares-Frias L, Cantalapiedra- Rodriguez R, Alvarez-Barcia A. Efficacy and safety of short-duration topical treatment with azithromycin oil-based eyedrops in an experimental model of corneal refractive surgery. Eur J Ophthalmol 2010;20:979-988.
20. Burns FR, Gray RD, Paterson CA. Inhibition of alkaliinduced corneal ulceration and perforation by a thiol peptide. Invest Ophthalmol Vis Sci 1990;31:107-114.
21. Avila M, Espana M, Moreno C, Pena C. Reconstruction of ocular surface with heterologous limbal epithelium and amniotic membrane in a rabbit model. Cornea 2001;20:414-420.
22. Von Fischern T, Lorenz U, Burchard WG, Reim M, Schrage NF. Changes in mineral composition of rabbit corneas after alkali burn. Graefes Arch Clin Exp Ophthalmol 1998;236:553-558.
23. Moseley TA, Zhu M, Hedrick MH. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 2006;118:121S-128S.
24. Kim M, Choi YS, Yang SH, Hong HN, Cho SW, Cha SM, et al. Muscle regeneration by adipose tissue-derived adult stem cells attached to injectable PLGA spheres. Biochem Biophys Res Commun 2006;348:386-392.
25. Conejero JA, Lee JA, Parrett BM, Terry M, Wear-Maggitti K, Grant RT, et al. Repair of palatal bone defects using osteogenically differentiated fat-derived stem cells. Plast Reconstr Surg 2006;117:857-363.
26. Beltrami AP, Cesselli D, Bergamin N, Marcon P, Rigo S, Puppato E, et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 2007;110:3438-3446.
27. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
28. Ferro F, Spelat R, Falini G, Gallelli A, Ltaurizio F, Puppato E, et al. Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. Am J Pathol 2011;178:2299-2310.
29. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
30. Tobita M, Orbay H, Mizuno H. Adipose-derived stem cells: current findings and future perspectives. Discov Med 2011;11:160-170.
31. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008;45:115-120.
32. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009;20:419-427.
33. Patel SA, Sherman L, Munoz J, Rameshwar P. Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz) 2008;56:1-3.
34. Boquest AC, Shahdadfar A, Fronsdal K, Sigurjonsson O, Tunheim SH, Collas P, et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 2005;16:1131-1141.
35. Du Y, Carlson EC, Funderburgh ML, Birk DE, Pearlman E, Guo N, et al. Stem cell therapy restores transparency to defective murine corneas. Stem Cells 2009;27:1635-1642.
36. Agorogiannis GI, Alexaki VI, Castana O, Kymionis GD. Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect. Graefes Arch Clin Exp Ophthalmol 2012;250:455-457.